LanZhou Foci Pharmaceutical Co.,Ltd. (SHE:002644)
China flag China · Delayed Price · Currency is CNY
9.93
+0.28 (2.90%)
Feb 4, 2026, 3:04 PM CST

SHE:002644 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Operating Revenue
892.97977.451,1581,041809.39659.96
Other Revenue
2.782.785.451.588.258.09
895.75980.231,1631,042817.64668.05
Revenue Growth (YoY)
-9.41%-15.73%11.58%27.49%22.39%6.24%
Cost of Revenue
618.46681.46804.17738.23596.57503.63
Gross Profit
277.29298.76358.96304.16221.07164.42
Selling, General & Admin
161.02184.21236.74181.6131.27119.61
Research & Development
25.5929.2830.9323.5619.3615.38
Other Operating Expenses
10.9511.3713.3214.5314.8212.04
Operating Expenses
235.06254.63296.07238.06175.42151.14
Operating Income
42.2344.1362.966.145.6513.28
Interest Expense
-1.54-0.83-1.24-1.35-0.95-1.28
Interest & Investment Income
4.595.745.377.5110.212.82
Currency Exchange Gain (Loss)
0.30.31.082.15-0.33-0.37
Other Non Operating Income (Expenses)
-4.5-3.95-1.43-17.88-1.220.89
EBT Excluding Unusual Items
41.0745.3866.6756.5353.3625.34
Gain (Loss) on Sale of Investments
-6.33-7.23-4.49-1.3-0.85-4.05
Gain (Loss) on Sale of Assets
0.030.04-027.1870.59
Asset Writedown
0.02--0-0.2-0.370.15
Legal Settlements
----0.01-
Other Unusual Items
30.9430.9419.4675.6831.4838.48
Pretax Income
65.7469.1481.64130.72110.81130.52
Income Tax Expense
7.387.4713.5221.3717.322.81
Earnings From Continuing Operations
58.3661.6768.12109.3593.52107.71
Minority Interest in Earnings
0.72-1.6-0.93-0.69-0.260.31
Net Income
59.0860.0767.19108.6593.26108.02
Net Income to Common
59.0860.0767.19108.6593.26108.02
Net Income Growth
27.94%-10.60%-38.16%16.51%-13.66%44.31%
Shares Outstanding (Basic)
511511511511511511
Shares Outstanding (Diluted)
511511511511511511
Shares Change (YoY)
-0.03%0.05%-0.01%-0.03%0.00%0.03%
EPS (Basic)
0.120.120.130.210.180.21
EPS (Diluted)
0.120.120.130.210.180.21
EPS Growth
27.98%-10.64%-38.16%16.54%-13.66%44.27%
Free Cash Flow
132.3725.743.2445.08-20.95-59.69
Free Cash Flow Per Share
0.260.050.090.09-0.04-0.12
Dividend Per Share
0.0120.0120.0300.0500.0100.120
Dividend Growth
-60.00%-60.00%-40.00%400.00%-91.67%100.00%
Gross Margin
30.96%30.48%30.86%29.18%27.04%24.61%
Operating Margin
4.71%4.50%5.41%6.34%5.58%1.99%
Profit Margin
6.60%6.13%5.78%10.42%11.41%16.17%
Free Cash Flow Margin
14.78%2.62%3.72%4.32%-2.56%-8.94%
EBITDA
90.5493.76114.29114.9693.5858.42
EBITDA Margin
10.11%9.56%9.83%11.03%11.45%8.74%
D&A For EBITDA
48.349.6351.3948.8647.9245.13
EBIT
42.2344.1362.966.145.6513.28
EBIT Margin
4.71%4.50%5.41%6.34%5.58%1.99%
Effective Tax Rate
11.23%10.81%16.56%16.35%15.61%17.48%
Revenue as Reported
895.75980.231,1631,042817.64668.05
Advertising Expenses
-7.6837.8622.2915.7322.32
Source: S&P Global Market Intelligence. Standard template. Financial Sources.